glp-1 agonist and dpp-4 inhibitor Cardiovascular effects of the inhibitors Clinical Use of DPP-4 Inhibitors

36 Several other recent studies also confirmed that tirzepatide treatment is superior to other GLP-1 RAs and placebo in promoting meaningful weight loss

Acute Kidney Injury On the FDA label for Ozempic, acute kidney injury and worsening of chronic renal failure is listed as a potential adverse reaction

Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology

Both are GLP-1 receptor agonists used to help manage type 2 diabetes and, in some cases, to support weight loss under medical supervision

Diabetes Care 28:10921100 Semenya AM, Wilson SA (2020) Oral Semaglutide (Rybelsus) for the Treatment of Type 2 Diabetes Mellitus